Condition: Pathologic Processes · Diabetes Mellitus · Glucose Metabolism Disorders · Sponsor: C5 Biomedical
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
This description comes directly from the study's public registry record.
Bennett Rogers · 888-960-1343 · Brogers@serenagroups.com
Connie Chung, PhD · 734-730-3058 · Connie@c5biomedical.com
Always discuss trial participation with your own doctor first.
| Poirot Podiatry | Metairie, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06674980